[INQ. NO. 2602E08] Chungwoo Medical, a specialized aesthetic medical device manufacturer with 25 years of experience, develops and manufactures energy-based medical devices, including radiofrequency (RF) and high-intensity focused ultrasound (HIFU) ― using proprietary technology.
With approximately 30% of its workforce dedicated to research and development and approximately 20% of its revenue reinvested in R&D, Chungwoo Medical has focused on advancing its products with clinical efficacy, safety, and user convenience in mind.

Leveraging this technological prowess, Chungwoo Medical’s products are currently supplied to over 70 countries worldwide, including those in Asia, Europe, the Middle East, and the Americas. The company is steadily securing key global certifications, including the EU’s MDR, the U.S. FDA, and Brazil’s ANVISA, thereby building its credibility in the international market.
At KIMES 2026, Chungwoo Medical plans to showcase its new aesthetic medical devices targeting the global market on an international stage, and to actively pursue overseas export sales and new distribution partners. During the exhibition, the company will conduct consultations tailored to each country’s distribution structure and regulatory requirements, based on product competitiveness, core technologies, and clinical data. It aims to establish mid- to long-term global partnerships by linking follow-up meetings and contract negotiations after the exhibition.
The APOLEX Tite, a key product to be showcased at the exhibition, is a medical device utilizing the Inside Monopolar Radiofrequency (IMR) method. Its design utilizes a patented, ultra-small temperature-sensing cannula to deliver high-frequency current to tissue to induce coagulation.
The 18g cannula minimizes the incision area, and a real-time temperature sensor enables energy control approximately 5°C before the set temperature is reached, ensuring a more stable treatment environment.

Furthermore, the device measures and controls tissue impedance in real time during the procedure, minimizing the impact on surrounding tissue and reducing the risk of charring or burns.
The ELLISYS SENSE is a medical device that uses high-frequency current to induce tissue coagulation. It features a double-shot design that delivers thermal energy to two skin layers in a single shot. It utilizes a vacuum suction system to maintain stable contact with the skin, and by controlling the needle insertion depth, it ensures even energy delivery to the target layer. Accordingly, this reduces treatment time, providing a more precise treatment environment.

The CONTLEX SENSE is a non-invasive, high-intensity focused ultrasound (HIFU) device featuring precise energy control using a magnetic cartridge. The two-way round-trip irradiation method was applied to increase the efficiency of the procedure. The two types of handpieces – line type and pen type – are supplied to enable flexible application according to the area and purpose of treatment.
Chungwoo Medical is expanding its global business into South America, the Middle East, some Asian nations, the Unites States, and Europe. By entering the market with FDA and CE certifications, the company plans to enhance brand credibility and expand its reach. Furthermore, it intends to strengthen its distribution network in South America and the Middle East to meet the growing demand for its non-invasive, energy-based devices.
Meanwhile, Chungwoo Medical plans to expand its reach with global buyers and medical professionals by participating in major international exhibitions, including IMCAS Paris, IMCAS America, IMCAS Asia, and Dubai Derma, following its participation in KIMES 2026. By launching R&D-driven new products and securing global certifications, the company plans to gradually strengthen its position as a leading K-aesthetic medical device brand.

 
korean-electronics.com | Blog Magazine of korean electronics, brands and Goods